How FDA Announcements Have Resulted In Altria's Stock Being Undervalued - News Summed Up

How FDA Announcements Have Resulted In Altria's Stock Being Undervalued


The good news is that this has brought about a situation where Altria’s stock looks undervalued. Altria generates its revenues from four sources – smokeable products, smokeless products, wine, and financial services. TrefisThe smokeless segment delivered an impressive 11% operating companies income growth in 2017, despite a voluntary recall of some smokeless tobacco products. The high-priced fine wine segment suffered a decline during the economic recession as the trend was towards inconspicuous consumption as consumers traded down to value-priced wines. Consequently, we expect an improvement in the volume and revenue per case metrics for the wine segment.


Source: Forbes March 27, 2018 15:22 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */